Areas of Interest: Vector Biology, Chemical Biology, Insecticide Resistance, Malaria, Mosquito Biology, Pharmacokinetics, Proteomics
Academic Background and Professional Role Dr. Hanafy Ismail is a Lecturer at LSTM and leads the Chemical Biology Group (HI-Lab). He holds a BSc and MSc in Pesticide Chemistry and Toxicology from Alexandria University, Egypt, and joined LSTM in 2007 to work on molecular aspects of drug and insecticide resistance.
Research Dr. Ismail’s research focuses on understanding and mitigating insecticide resistance in mosquitoes, which is a major challenge in vector control. He leads efforts to predict and manage insecticide resistance using advanced chemical biology techniques, including ADME analysis, proteomics, and genetic approaches (for more details, visit the IRPP webpage). His work aims to identify resistance mechanisms and develop effective strategies to combat resistance, ultimately improving the efficacy of malaria vector control interventions.
Funding
- $3,628,363 - Bill & Melinda Gates Foundation (November 2023 – December 2027): PI Hanafy M. Ismail, Co-PIs Hilary Ranson, David Weetman, and Mark Paine. Forewarned is forearmed: developing an Insecticide Resistance Prediction Platform (IRPP) to identify cross-resistance mechanisms to new insecticides for proactive management of next-generation malaria vector control products. Grant Number: INV-062098.
- $599,456 - Global Fund Project (December 2023 – December 2024): Entomological investigations and stakeholder perspectives to support the introduction of dual active ingredient ITNs into the wider vector control space. Prof. Charles Wondji (PI, CRID), Dr. Magellan Tchouakui (Site-PI, CRID), Dr. Hanafy Ismail (Co-I, LSTM), Prof. Hilary Ranson (Co-PI, LSTM), Dr. Rosemary Lees (Co-PI, LSTM), Dr. Moussa W. Guelbeogo (Co-PI, CNRFP), Dr. Antoine Sanou (Site-PI, CNRFP). Subcontract: $199,978 - Hanafy M. Ismail (PI, LSTM on Study 2). Grant ID: TGF-23-8.
- £50,000 - GCRF Anti-Vec Pump Priming Project: Hanafy M. Ismail (PI) and Mark Paine (Co-PI). Modulation of the steroid hormone signalling via chemical inhibition of CYP314A1 in Anopheline mosquitoes for malaria control.
- £3,654,460 - Innovative Vector Control Consortium (IVCC) (January 2022 – December 2024): LITE GLP facility. PI Hilary Ranson, Co-PIs Mark Paine and Hanafy Ismail.
- £962,023 - Medical Research Council (February 2021 –December 2024): Pre-emptive discovery of insecticide cross-resistance mechanisms for next-generation malaria control products. Mark Paine (P.I.), Co-PIs Hanafy M. Ismail, David Weetman, Gareth Lycett (LSTM).